key: cord-0805245-bu8gt6d2
authors: Baka, Margarita; Michos, Athanasios; Alexopoulou, A.; Bouka, P.; Bouka, E.; Dana, E.; Dimitriou, G.; Doganis,; Grivea, I.; Ioannidou, M.; Kourti, M.; Magkou, E.; Makis, A.; Malama, A.; Mantadakis, E.; Markozannes, G.; Mitsios, A.; Moschovi, M.; Papadakis, V.; Panagopoulou, P.; Papakonstantinou, E.; Papadopoulos, S.; Polychronopoulou, S.; Themistocleous, M.; Tzotzola, V.; Ntzani, Evangelia; Petridou, Eleni Th
title: COVID‐19 among children with cancer in Greece (2020): Results from the Nationwide Registry of Childhood Hematological Malignancies and Solid Tumors (NARECHEM‐ST)
date: 2021-05-15
journal: Pediatr Blood Cancer
DOI: 10.1002/pbc.29079
sha: de68daee877f35b3c88feb016b21adb9582d54ba
doc_id: 805245
cord_uid: bu8gt6d2

nan

To the Editor:

The impact of coronavirus disease 2019 (COVID-19) varies by age and chronic disease group. Children are generally at low risk for serious complications 1 ; children with cancer (CwC), however, are vulnerable to infections mainly due to immunosuppression caused by treatment. 2 We aimed to assess the magnitude and severity of COVID-19 among 

Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults

Clinical presentations and outcomes of children with cancer and COVID-19: a systematic review

Pediatric cancer registration fluctuation in Greece due to COVID-19 pandemic and changes in health care delivery

COVID-19 in children with cancer in New York City

Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment

SARS-CoV-2 molecular testing in Greek hospital paediatric departments: a nationwide study

Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children

SUPPORTING INFORMATION Additional supporting information may be found online in the Supporting Information section at the end of the article